News and Events

Many businesses today are starting to take notice of social media platforms as viable channels for two-way communication with their clients and business stakeholders. Because of this, UF PathLabs recently developed a Facebook page.

The 2011 University of Florida Pathology Laboratories Test Directory is now available for download. In this more than 150-page document, you can learn about UF PathLabs and the tests we perform in 2011, including details on:

Test names and methodologies | The days of the week each test is performed | Test result turnaround times
How test results are delivered | The conditions each test is used to identify | Specimen requirements
Reference values | Shipping requirements | CPT codes

As of Feb. 7, 2011, molecular positioning of CGH microarray findings generated by UF PathLabs' cytogenetics laboratory will be reported relative to human genome content available to the public and sourced from the UCSC Genome BrowserGRCh/hg19human genome; NCBI build 37.1, Feb. 2009.

Internal validation of the ISCA 180k CGH microarray has been completed by our our laboratory and is now currently available as part of our testing menu. This array format will replace the previous 44k format as the default testing modality utilized for all new and pending congenital aCGH testing requests.

If you have questions regarding the availability or applications of specific microarray platforms, call the laboratory at
(352) 265-9900.

All current requests for CGH microarray studies will be processed utilizing a 44k oligonucleotide platform which has been validated and is available through our laboratory for clinical use.

Validation of additional platforms and/or formats (i.e., 180k) are underway and will be made available for clinical use following successful internal validation. Notice of availability of additional platforms or formats will be posted here.

The use of ISCN (2005) nomenclature will be discontinued for clinical laboratory reports issued from the UF Cytogenetics Laboratory beginning 04/15/09. All nomenclature used in the cytogenetic, FISH, and aCGH diagnoses fields in future laboratory reports will conform to the current International System for Human Cytogenetic Nomenclature (2009), as required per C.A.P. (see CYG.32100).

The use of common gene name aliases/synonyms (i.e., ABL for ABL1,TEL for ETV6, ETO for RUNX1T1, etc.) will be phased out in FISH nomenclature used in diagnostic reports and will be replaced by official gene names as found listed in the NCBI's Reference Sequence project (RefSeq).

The text interpretation portion of FISH reports have been restructured to place the bolded "normalcy or abnormalcy" statement on the initial line of text, followed by a text description of the type of abnormality, if present.